DETERIORATION OF RENAL FUNCTION WITH INCREASED MORTALITY IN PATIENTS WITH HEART FAILURE (HF)

Authors

  • Basher Kareem Mohammed M.B.Ch.B.-FIBMS Iraqi Ministry of Health, Kirkuk Health Department, Kirkuk General Hospital, Kirkuk, Iraq.
  • Fadhil Faidhalla Mohialdeen Iraqi Ministry of Health, Kirkuk Health Department, Kirkuk General Hospital, Kirkuk, Iraq .
  • Mohaned Adel Jayan M.B.Ch.B.-MSc Respiratory Medicine Iraqi Ministry of Health, Thi Qar Health Office, Al-Hussein Teaching Hospital, Thi-Qar, Iraq.

Keywords:

FGe, CKD, HF, Renal Failure

Abstract

This study was conducted on patients who suffer from deterioration in kidney function, and this has another effect on heart failure. Information about patients such as age and gender was collected, in addition to the general characteristics of patients. The results are presented as a mean (M) and a mean (SD) standard deviation. To compare the quantitative indicators of two independent groups with the normal distribution of the trait, Student (t-test) was used. Differences were considered significant at P < 0.05. It was found that there were four stages between time one and time 2, stage 2 was kidney damage and a slight decrease in GFR 60 to 89 ml/min and stage 3 moderate decrease in GFR 30 to 59 ml/min as for stage 4 severe decrease in glomerular filtration rate from 15 to 29 ml/min and stage 5 stable renal failure less than 15 ml/min or when hemodialysis, statistically significant differences between the two stages were found greater or equal to 0.05 and FGe>60 ml/min was found at time 2 for patients While it was not found at the beginning of the study Through the results, we conclude that there is a positive relationship between the parameters (deterioration of renal function and mortality in patients with heart failure), and this study is our findings support the hypothesis that renal impairment could be a marker for worsening HF.

References

Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Writing Group Members, Mozzafarian D, Benjamin EJ, et al. Circulation. 2016; 133:0–360. [Google Scholar]

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Mosterd A, Hoes AW, de Bruyne MC, et al. Eur Heart J. 1999;20:447–455.

Epidemiology and risk profile of heart failure. Bui AL, Horwich TB, Fonarow GC. Nat Rev Cardiol. 2011; 8:30–41. [PMC free article]

Rehospitalization for heart failure problems and perspectives. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. J Am Coll Cardiol. 2013; 61:391–403.

Epidemiology of chronic kidney disease in heart failure. Ahmed A, Campbell RC. Heart Fail Clin. 2008; 4:387–399. [PMC free article]

Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Go AS, Mozaffarian D, Roger VL, et al. Circulation. 2013; 127:143–152.

Long-term trends in the incidence of and survival with heart failure. Levy D, Kenchaiah S, Larson MG, et al. N Engl J Med. 2002;347:1397–1402.

Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Mozaffarian D, Benjamin EJ, Go AS, et al. Circulation. 2015; 131:0–322.

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Adams KF Jr, Fonarow GC, Emerman CL, et al. Am Heart J. 2005;149:209–216.

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. Heywood JT, Fonarow GC, Costanzo MR, et al. J Card Fail. 2007; 13:422–430.

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. Al-Ahmad A, Rand WM, Manjunath G, et al. J Am Coll Cardiol. 2001; 38:955–962.

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Hunt SA, Abraham WT, Chin MH, et al. Circulation. 2005; 112:0.

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Masoudi FA, Rathore SS, Wang Y, et al. Circulation. 2004; 110:724–731.

Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. Ahmed A, Allman RM, DeLong JF, Bodner EV, Howard G. https://www.ncbi.nlm.nih.gov/pubmed/12144075. South Med J. 2002; 95:703–710.

Subgroup analysis in randomised controlled trials: importance, indications, and intepretation. Rothwell PM. Lancet. 2005; 365:176–186.

Relationship between hospital readmission and mortality rates for patients hospitalzed with acute myocardial infarction, heart failure, or pneumonia. Krumholz HM, Lin Z, Keenan PS, et al. J Am Med Assoc. 2013;309:587–593. [PMC free article]

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure a report from the OPTIMIZE-HF registry. Fonarow GC, Stough WG, Abraham WT, et al. J Am Coll Cardiol. 2007; 50:768–777.

Renal impairment and outcomes in heart failure: systematic review and meta-analysis. Smith GL, Lichtman JH, Bracken MB, et al. J Am Coll Cardiol. 2006; 47:1987–1996.

Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure. Komukai K, Ogawa T, Yag Hi, et al. Circ J. 2008;72:1152–1157.

Kidney function and mortality among patients with left ventricular systolic dysfunction. Khan NA, Ma I, Thompson CR, et al. J Am Soc Nephrol. 2006; 17:244–253.

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. Mullens W, Abrahams Z, Francis GS, et al. J Am Coll Cardiol. 2009; 53:589–596. [PMC free article]

Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Testani JM, McCauley BD, Kimmel SE, Shannon RP. Am J Cardiol. 2010; 106:1763–1769. [PMC free article]

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. Damman K, Navis G, Voors AA, et al. J Card Fail. 2007; 13:599–608.

Downloads

Published

2022-03-08

How to Cite

Basher Kareem Mohammed, Fadhil Faidhalla Mohialdeen, & Mohaned Adel Jayan. (2022). DETERIORATION OF RENAL FUNCTION WITH INCREASED MORTALITY IN PATIENTS WITH HEART FAILURE (HF). World Bulletin of Public Health, 8, 1-12. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/634

Issue

Section

Articles

Most read articles by the same author(s)